Fate Therapeutics, Inc. (FATE)
1.28
-0.06
(-4.48%)
USD |
NASDAQ |
Nov 13, 16:00
1.275
0.00 (0.00%)
After-Hours: 19:59
Fate Therapeutics Market Cap : 155.56M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 155.56M |
| November 12, 2026 | 162.86M |
| November 11, 2026 | 195.06M |
| November 10, 2026 | 215.12M |
| November 09, 2026 | 235.78M |
| November 06, 2026 | 223.01M |
| November 05, 2026 | 224.84M |
| November 04, 2026 | 254.01M |
| November 03, 2026 | 247.93M |
| November 02, 2026 | 234.56M |
| October 30, 2026 | 242.72M |
| October 29, 2026 | 253.23M |
| October 28, 2026 | 253.23M |
| October 27, 2026 | 241.56M |
| October 26, 2026 | 239.81M |
| October 23, 2026 | 246.22M |
| October 22, 2026 | 243.89M |
| October 21, 2026 | 241.56M |
| October 20, 2026 | 240.39M |
| October 19, 2026 | 217.05M |
| October 16, 2026 | 208.88M |
| October 15, 2026 | 224.64M |
| October 14, 2026 | 226.39M |
| October 13, 2026 | 233.39M |
| October 12, 2026 | 248.56M |
| Date | Value |
|---|---|
| October 09, 2026 | 254.39M |
| October 08, 2026 | 248.56M |
| October 07, 2026 | 250.89M |
| October 06, 2026 | 267.23M |
| October 05, 2026 | 283.57M |
| October 02, 2026 | 270.73M |
| October 01, 2026 | 268.40M |
| September 30, 2026 | 276.56M |
| September 29, 2026 | 277.73M |
| September 28, 2026 | 277.73M |
| September 25, 2026 | 274.23M |
| September 24, 2026 | 271.90M |
| September 23, 2026 | 283.57M |
| September 22, 2026 | 301.07M |
| September 21, 2026 | 295.24M |
| September 18, 2026 | 295.24M |
| September 17, 2026 | 294.07M |
| September 16, 2026 | 284.73M |
| September 15, 2026 | 274.23M |
| September 14, 2026 | 273.06M |
| September 11, 2026 | 269.56M |
| September 10, 2026 | 271.90M |
| September 09, 2026 | 284.73M |
| September 08, 2026 | 291.74M |
| September 04, 2026 | 289.40M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AVITA Medical, Inc. | 483.94M |
| Agenus, Inc. | 304.25M |
| Amgen, Inc. | 251.88B |
| Anika Therapeutics, Inc. | 179.48M |
| BioCryst Pharmaceuticals, Inc. | 1.949B |
Market Cap Related Metrics
| PS Ratio | 32.56 |
| Price to Book Value | 1.169 |
| Price | 1.28 |
| Earnings Yield | -80.48% |